Video Roundtable: Industry Leaders Talk COVID-19, Strategy And The Year Ahead
Accord, mAbxience, PharmEvo And Sandoz Leaders Discuss Priorities For The Sector
Executive Summary
In this exclusive video roundtable discussion, leaders from across the off-patent industry talk about the COVID-19 pandemic and the industry’s response, as well as highlighting key regulatory, policy and strategic developments that may have flown under the radar in the past year.
You may also be interested in...
Mabxience Expands Biosimilar Capacity
Mabxience has announced plans to bolster its biosimilar manufacturing capacity as well as giving a boost to its CDMO business by expanding its facility in León, Spain.
Accord Takes A Trio Of Awards
Accord Healthcare took home a trio of prizes at the Global Generics & Biosimilars Awards 2020, with other winners including Alvogen, Aurobindo, Dr Reddy’s, Eurofarma, Insud Pharma, Macleods, Pinsent Masons, Samsung Bioepis, Sandoz, Stada and Zentiva.
Action Needed To Prevent Post-Brexit Catastrophe In Northern Ireland
Action is needed from both the UK government and the European Commission to prevent a collapse of Northern Ireland’s generics market, according to the BGMA.